Publications:

Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes.

Communications Biology

Dong, Xiaobao X; Huang, Dandan D; Yi, Xianfu X; Zhang, Shijie S; Wang, Zhao Z; Yan, Bin B; Chung Sham, Pak P; Chen, Kexin K; Jun Li, Mulin M

Publication Date: 2020-01-07

Variant appearance in text: PIK3CA: f95a

PubMed Link: 31925297

Variant Present in the following documents:

• 42003_2019_736_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

The Hippo signaling pathway provides novel anti-cancer drug targets.

Oncotarget

Bae, June Sung JS; Kim, Sun Mi SM; Lee, Ho H

Publication Date: 2017-02-28

Variant appearance in text: PI3K: F95A

PubMed Link: 28035075

Variant Present in the following documents:

• Main text
• oncotarget-08-16084.pdf

View BVdb publication page

Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide-3-kinase.

Cell Cycle (Georgetown, Tex.)

Sun, Minghao M; Hart, Jonathan R JR; Hillmann, Petra P; Gymnopoulos, Marco M; Vogt, Peter K PK

Publication Date: 2011-11-01

Variant appearance in text: PI3K: F95A

PubMed Link: 22045127

Variant Present in the following documents:

• Main text

View BVdb publication page